·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ [Þäͱ]'µå·°ÀÎÆ÷' ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü ±â»çÀÔ·Â : 02.04.16 16:07:00 0 °¡ ÇÃÄ£Ãß°¡ ÀÌ¿ëÀÚ ÆøÁÖ·Î °Ë»ö¼Óµµ °³¼±ÀÛ¾÷µµ º´Çà ±¹³» ÃÖ´ë±Ô¸ðÀÇ ÀǾàǰ µ¥ÀÌÅͺ£À̽º 'µå·°ÀÎÆ÷'(µ¥Àϸ®ÆÊ/ºñÆ® Á¦ÈÞ) °Ë»ö¼ºñ½º°¡ ¾÷±×·¹ÀÌµå °ü°è·Î ÀÌ´Þ¸»±îÁö '¼ººÐ¸í °Ë»ö±â´É'ÀÌ ÀϽà Áߴܵ˴ϴÙ. ¾Æ¿ï·¯ ÀÌ¿ëÀÚµéÀÇ ÆøÁÖ·Î °Ë»ö¼Óµµ°¡ ´Ù¼Ò ´À·ÁÁø ¹®Á¦¸¦ ÇØ¼ÒÇϱâ À§ÇÑ '¼Óµµ°³¼±' ÀÛ¾÷µµ º´ÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿ëÀÚ ¿©·¯ºÐµéÀÇ ¸¹Àº ¾çÇØ¸¦ ±¸Çϸç, º¸´Ù ´õ ³ºÀº ¼ºñ½º¸¦ À§ÇØ ÃÖ¼±À» ´ÙÇϰڽÀ´Ï´Ù. °¨»çÇÕ´Ï´Ù. µ¥Àϸ®ÆÊ X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ µ¥Àϸ®ÆÊ(dailypharm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [Þäͱ]µå·°ÀÎÆ÷ ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ [Þäͱ]'µå·°ÀÎÆ÷' ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü ±â»çÀÔ·Â : 02.04.16 16:07:00 0 °¡ ÇÃÄ£Ãß°¡ ÀÌ¿ëÀÚ ÆøÁÖ·Î °Ë»ö¼Óµµ °³¼±ÀÛ¾÷µµ º´Çà ±¹³» ÃÖ´ë±Ô¸ðÀÇ ÀǾàǰ µ¥ÀÌÅͺ£À̽º 'µå·°ÀÎÆ÷'(µ¥Àϸ®ÆÊ/ºñÆ® Á¦ÈÞ) °Ë»ö¼ºñ½º°¡ ¾÷±×·¹ÀÌµå °ü°è·Î ÀÌ´Þ¸»±îÁö '¼ººÐ¸í °Ë»ö±â´É'ÀÌ ÀϽà Áߴܵ˴ϴÙ. ¾Æ¿ï·¯ ÀÌ¿ëÀÚµéÀÇ ÆøÁÖ·Î °Ë»ö¼Óµµ°¡ ´Ù¼Ò ´À·ÁÁø ¹®Á¦¸¦ ÇØ¼ÒÇϱâ À§ÇÑ '¼Óµµ°³¼±' ÀÛ¾÷µµ º´ÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿ëÀÚ ¿©·¯ºÐµéÀÇ ¸¹Àº ¾çÇØ¸¦ ±¸Çϸç, º¸´Ù ´õ ³ºÀº ¼ºñ½º¸¦ À§ÇØ ÃÖ¼±À» ´ÙÇϰڽÀ´Ï´Ù. °¨»çÇÕ´Ï´Ù. µ¥Àϸ®ÆÊ X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ µ¥Àϸ®ÆÊ(dailypharm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¾È¼º/Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â ä¿ë ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °Ç±â½Ä»ç¾÷ÆÀ ¸¶ÄÉÆÃ, ¿µ¾÷, °³¹ß ºÎ¹®º° ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [Þäͱ]µå·°ÀÎÆ÷ ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ [Þäͱ]'µå·°ÀÎÆ÷' ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü ±â»çÀÔ·Â : 02.04.16 16:07:00 0 °¡ ÇÃÄ£Ãß°¡ ÀÌ¿ëÀÚ ÆøÁÖ·Î °Ë»ö¼Óµµ °³¼±ÀÛ¾÷µµ º´Çà ±¹³» ÃÖ´ë±Ô¸ðÀÇ ÀǾàǰ µ¥ÀÌÅͺ£À̽º 'µå·°ÀÎÆ÷'(µ¥Àϸ®ÆÊ/ºñÆ® Á¦ÈÞ) °Ë»ö¼ºñ½º°¡ ¾÷±×·¹ÀÌµå °ü°è·Î ÀÌ´Þ¸»±îÁö '¼ººÐ¸í °Ë»ö±â´É'ÀÌ ÀϽà Áߴܵ˴ϴÙ. ¾Æ¿ï·¯ ÀÌ¿ëÀÚµéÀÇ ÆøÁÖ·Î °Ë»ö¼Óµµ°¡ ´Ù¼Ò ´À·ÁÁø ¹®Á¦¸¦ ÇØ¼ÒÇϱâ À§ÇÑ '¼Óµµ°³¼±' ÀÛ¾÷µµ º´ÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿ëÀÚ ¿©·¯ºÐµéÀÇ ¸¹Àº ¾çÇØ¸¦ ±¸Çϸç, º¸´Ù ´õ ³ºÀº ¼ºñ½º¸¦ À§ÇØ ÃÖ¼±À» ´ÙÇϰڽÀ´Ï´Ù. °¨»çÇÕ´Ï´Ù. µ¥Àϸ®ÆÊ X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ µ¥Àϸ®ÆÊ(dailypharm@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : [Þäͱ]µå·°ÀÎÆ÷ ¼ººÐ¸í °Ë»ö ÀϽà Áß´Ü URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö